Adyen expands partnership with Affirm to UK
Adyen has expanded its alliance with Affirm to the UK, enabling merchants to offer a range of pay-over-time plans to their customers.
This service aims to provide consumers with various payment options, including interest-free and interest-bearing instalments.
The collaboration began in November 2020, offering Affirm's payment solutions to eligible US merchants through various platforms, including websites, apps, and physical payment terminals.
The partnership has experienced a 'growth' in average annual volume, increasing 'more than seven times' from 2021 to 2023, the release stated.
Adyen UK managing director Nicole Olbe said: 'Adyen customers all over the globe are demanding best-in-class payment experiences to boost business and drive customer engagement, which is why we are expanding our partnership with Affirm into the U.K.
'We've seen how Affirm's consumer-first payment options accelerate growth for our U.S. and Canadian merchants and help them meet customers' individual needs at checkout. We're excited to unlock greater opportunities for U.K. merchants, and greater flexibility for consumers, together with Affirm.'
Affirm VP and UK country manager Ruth Spratt stated: "Businesses across many sectors in the U.K. rely on Adyen to drive growth; now they can benefit by offering Affirm's more flexible, transparent, and long-term pay-over-time options to their customers.
'By deepening our partnership with Adyen, we look forward to helping more merchants to grow their business, and more consumers pay over time on a schedule that works best for them, and always without any late or hidden fees."
In November 2024, Affirm expanded to the region with the launch of Affirm UK with the regulatory approval by the Financial Conduct Authority.
In December 2024, the partnership further expanded to include Adyen for Platforms customers in the US and Canada.
Additionally, Adyen introduced Adyen Uplift, an AI-powered suite designed to optimise payment processes.
"Adyen expands partnership with Affirm to UK " was originally created and published by Electronic Payments International, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
38 minutes ago
- Yahoo
Viemed Healthcare Announces Share Repurchase Program
LAFAYETTE, La., June 09, 2025 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the 'Company' or 'Viemed') (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that its Board of Directors has authorized a share repurchase program, effective through June 2026. Under the share repurchase program, Viemed may purchase up to 1,976,441 common shares of the Company ('the Common Shares') from time to time in accordance with applicable securities laws, representing approximately 5% of the total issued and outstanding Common Shares as of March 31, 2025. The Company intends to repurchase Common Shares through open market purchases, block purchases or otherwise in accordance with applicable securities laws. Subject to certain exceptions for block purchases, daily purchases will be limited to 25% of the average daily volume for the four calendar weeks preceding the date of purchase. Casey Hoyt, Viemed's Chief Executive Officer, noted, 'Our recent first quarter 2025 results and the increases in our 2025 guidance range midpoints demonstrate that we are executing well with strong underlying fundamentals in the business. We have a track record of disciplined capital allocation, with our latest example being the attractive acquisition of Lehan's Medical that is expected to close in the third quarter of this year. Since our public listing, we have repurchased approximately 2.6 million shares, underscoring our commitment to executing on our capital allocation strategies. With no net debt and full availability on our $55 million credit facility, we have ample liquidity to improve shareholder value with a new share repurchase program while also funding our organic and inorganic growth initiatives.' The price paid for the Common Shares will be the market price at the time of purchase, plus applicable brokerage fees, or such other prices as may be permitted by applicable securities laws. There can be no assurance as to the precise number of Common Shares that will be repurchased under the program, if any. The Company may discontinue its purchases at any time, subject to compliance with applicable securities laws. The Common Shares purchased by the Company will be cancelled. ABOUT VIEMED HEALTHCARE, INC. Viemed is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. Viemed focuses on efficient and effective in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. Visit our website at statements contained in this press release may constitute 'forward-looking statements' within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 or 'forward-looking information' as such term is defined in applicable Canadian securities legislation (collectively, 'forward-looking statements'). Often, but not always, forward-looking statements can be identified by the use of words such as 'plans', 'expects', 'is expected', 'budget', 'potential', 'scheduled', 'estimates', 'forecasts', 'intends', 'anticipates', 'believes', 'projects', or the negatives thereof or variations of such words and phrases or statements that certain actions, events or results 'will', 'should', 'may', 'could', 'would', 'might' or 'will be taken', 'occur' or 'be achieved' or the negative of these terms or comparable terminology. All statements other than statements of historical fact, including those that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance, including the Company's expectations regarding the amount and timing of any potential repurchases of Common Shares, the funding sources for such repurchases, the availability of Common Shares for such repurchases, and the anticipated benefits to shareholders of such repurchases, as well as about its pending acquisition of Lehan's Medical Equipment, such as expected purchase price, contingent payments, closing date, funding sources, and anticipated synergies and other benefits are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties that could cause actual results or outcomes to differ materially from those expressed in the forward-looking statements. Such statements reflect the Company's current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking statements to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include, without limitation: the general business, market and economic conditions in the regions in which the we operate; significant capital requirements and operating risks that we may be subject to; our ability to implement business strategies and pursue business opportunities; volatility in the market price of our common shares; the state of the capital markets; the availability of funds and resources to pursue operations; inflation; reductions in reimbursement rates and audits of reimbursement claims by various governmental and private payor entities; dependence on few payors; possible new drug discoveries; dependence on key suppliers; granting of permits and licenses in a highly regulated business; competition; disruptions in or attacks (including cyber-attacks) on our information technology, internet, network access or other voice or data communications systems or services; the evolution of various types of fraud or other criminal behavior to which we are exposed; difficulty integrating newly acquired businesses; the impact of new and changes to, or application of, current laws and regulations; the overall difficult litigation and regulatory environment; increased competition; increased funding costs and market volatility due to market illiquidity and competition for funding; critical accounting estimates and changes to accounting standards, policies, and methods used by us; and the occurrence of natural and unnatural catastrophic events or health epidemics or concerns, and claims resulting from such events or concerns, as well as other general economic, market and business conditions; and other factors beyond our control; as well as those risk factors discussed or referred to in the Company's disclosure documents filed with the U.S. Securities and Exchange Commission (the 'SEC') available on the SEC's website at including the Company's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and with the securities regulatory authorities in certain provinces of Canada available at Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking statements prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking statements are expressly qualified in their entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking statements. The forward-looking statements included in this press release are made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking statements, other than as required by applicable law. For further information, please contact: Investor Relationsir@ Tripp SullivanSCR Partners, LLC615-942-7077 Trae FitzgeraldChief Financial OfficerViemed Healthcare, Inc.337-504-3802
Yahoo
39 minutes ago
- Yahoo
EDC supported more than 27,800 businesses and facilitated more than $123 billion intrade-related activities
Canada's export credit agency releases its 2024 business results and ESG performance reports OTTAWA, ON, June 9, 2025 /CNW/ - Today, Export Development Canada (EDC) released its 2024 Integrated Annual Report, highlighting how the organization helped its customers grow their business beyond Canada to seize the vast trade opportunities that await them in the global marketplace. The report is complemented by additional environmental, social and governance (ESG) disclosures: 2024 Climate-Related Disclosure, and the 2024 Sustainable Bond Impact Report. In 2024, exporters faced a complex and rapidly evolving economic environment. During this period, EDC expanded its presence in key Indo-Pacific markets to support the trade diversification of Canadian exporters. EDC invested in medium-sized Canadian exporters, sharpening its focus on priority sectors, and maintained a strong commitment to sustainable and responsible business practices. "In 2024, global economic softness weighed on Canadian exporters. Slow domestic growth, higher-for-longer interest rates and slowing labour markets strained the economic outlook in many countries," said Alison Nankivell, EDC's President and CEO. "Those challenges, coupled with new market uncertainties towards the end of the year, have energized our customers to transition from continental to global traders as we strive to make it easier for them to secure new international business opportunities. This renewed interest in trade diversification and EDC's solutions have increased since the start of this year given the evolving nature of U.S. trade policies, and we're stepping up to support them." In 2024, EDC supported more than 27,800 customers with financial and knowledge solutions, with the vast majority being small and medium-sized businesses. We facilitated a total of $123.4 billion in exports, foreign investment and trade development activities, including $23.4 billion in business in emerging markets. This support contributed to over 475,800 domestic jobs and helped to generate $87 billion of Canada's GDP. "During an uncertain economic environment, we strategically deployed capital and took on risk to help more Canadian companies reach global markets—and we are continuing to do so in response to the current climate," said Scott Moore, EDC's Executive Vice-President and Chief Financial Officer. "We're motivated by findings that Canadian companies supported by EDC generate 23% more revenues, employ 16% more workers and are 6% more productive, according to our latest study with Statistics Canada." In 2024, EDC's net income increased to $915 million from $450 million in 2023. This was driven by higher net revenue, combined with unrealized gains on financial instruments carried at fair value. Our growing presence in the Indo-Pacific In 2024, EDC added three new representations in the Indo-Pacific, increasing the total number of representations to 11 in the region, including its Singapore branch. EDC opened representations in Ho Chi Minh City, Vietnam, Manila, Philippines, and most recently, Bangkok, Thailand (in 2025) to offer in-market support to attract more Canadian companies to the booming region and help them navigate local market complexities. EDC supported 1,529 customers and facilitated $13 billion in business volumes in the Indo-Pacific region in 2024. It also signed memorandums of understanding with several export credit agencies and market leaders to enable strong market access for Canadian exporters. Our support for Canada's medium-sized exporters and key sectors In 2024, we continued our strategic objective to support the international growth of Canada's medium-sized companies. In 2024, we served 1,175 medium-sized Canadian companies across our financial solutions. EDC is focusing on Canadian sectors that provide net-new growth for Canada, namely agri-food, critical minerals, the energy transition, advanced manufacturing and digital industries. Its goal is to highlight Canada's strengths on the global stage and improve trade competitiveness. For example, in the agri-food sector, EDC served 3,201 customers throughout the year, facilitating $21.7 billion in business. As a leading financier of Canada's cleantech industry, EDC served 500 cleantech customers in 2024, enabling $9.7 billion in business facilitated. Our commitment to responsible business Throughout the year, EDC maintained its commitment to responsible business. In 2024, we issued our sixth green bond valued at US$ 1 billion, helping to further attract capital for climate-focused investment and support for projects that generate positive environmental outcomes. Additionally, we deployed $1.3 billion in financing for 56 renewable energy projects. Through our inclusive trade efforts, we offered targeted support for Canadian companies owned by members of equity-seeking groups, focusing on companies owned by women and Indigenous people. This effort served 3,816 financial and non-financial customers and facilitated $2.5 billion in business and trade activities. For more information, read the 2024 Integrated Annual Report and the suite of supplemental ESG reports. About EDC Export Development Canada (EDC) is a financial Crown corporation dedicated to helping Canadian businesses make an impact at home and abroad. EDC has the financial products and knowledge Canadian companies need to confidently enter new markets, reduce financial risk and grow their business as they go from local to global. Together, EDC and Canadian companies are building a more prosperous, stronger and sustainable economy for all Canadians. For more information and to learn how we can help your company, call us at 1-800-229-0575 or visit SOURCE Export Development Canada View original content to download multimedia: Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
39 minutes ago
- Yahoo
Canada's Competition Bureau suing DoorDash over prices, discounts
OTTAWA (Reuters) -Canada's Competition Bureau said on Monday it was suing DoorDash and its Canadian subsidiary for allegedly advertising misleading prices and discounts. The bureau said in a statement that it found that consumers were unable to purchase food and other items at the advertised price on DoorDash's websites and mobile applications due to the addition of mandatory fees at checkout. The bureau said it was suing to stop DoorDash from what it called deceptive price and discount advertising. It is seeking a penalty from the companies and wants them to offer restitution to affected consumers. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
